HAE - Intuitive Surgical Gains 26% Year to Date: Here's Why | Benzinga
Intuitive Surgical (NASDAQ: ISRG) is witnessing strong momentum, with its shares having rallied 26.4% year to date compared with 6.1% growth of the industry. The S&P 500 composite has risen 17.6% during the said time frame.
With healthy fundamentals and strong growth opportunities, this Zacks Rank #3 (Hold) company appears to be a solid wealth creator for its investors at the moment.
Intuitive Surgical Inc., a Sunnyvale, CA-based company, designs, manufactures and markets the da Vinci surgical system, Ion endoluminal system, and related instruments and accessories. The company's key product portfolio, da Vinci surgical system, is an advanced robot-assisted surgical system. It comprises a surgeon's console, patient-side cart, 3-D vision system, da Vinci Skills Simulator and Firefly Fluorescence Imaging.
Image Source: Zacks Investment Research
The robot-based da Vinci surgical system enables minimally invasive surgeries that reduce the trauma associated with open surgery. ISRG also manufactures EndoWrist instruments, such as forceps, scissors, electrocautery tools, scalpels, and other surgical tools, including wrist joints for natural dexterity for various surgical procedures. The company operates through three segments — Instruments and Accessories, Systems and Services.
Catalysts Driving Growth
Investors are upbeat about Intuitive Surgical's robot-based da Vinci surgical system that has been a key driver for the company's performance since its launch in 1999. The demand for medical procedures started to improve in 2023 after being disrupted by the COVID-19 ...